Skip to content
Search

Latest Stories

Global First: NHSE unveils 'Artificial Pancreas' for type 1 Diabetes patients across England

Global First: NHSE unveils 'Artificial Pancreas' for type 1 Diabetes patients across England

NHSE has outlined a comprehensive 5-year implementation strategy to ensure equitable access to Artifical pancreas 

The National Health Services England (NHSE) is poised to revolutionise diabetes management with the introduction of the 'artificial pancreas', also known as the Hybrid Closed Loop system, to treat type 1 diabetes. This pioneering initiative, endorsed by the National Institute of Health Care and Excellence (NICE), represents a global first in healthcare innovation.


With 269,095 individuals grappling with type 1 diabetes in England, the Hybrid Closed Loop system is set to cater to tens of thousands of children and adults across the nation.

This cutting-edge device operates by seamlessly monitoring blood glucose levels and autonomously adjusting insulin dosage through a pump, by eliminating the need for regular insulin injections.

Furthermore, it holds the promise of averting life-threatening hypoglycaemic and hyperglycaemia episodes, mitigating significant risks associated with the condition.

To facilitate the identification of beneficiaries, NHSE has allocated a substantial sum of £2.5 million, ensuring that those who could benefit from this innovative solution receive the necessary support.

This initiative follows a successful pilot programme that equipped 835 adults and children with type 1 diabetes, resulting in significant enhancements to their condition management.

Dr Clare Hambling, National Clinical Director for diabetes, voiced optimism regarding the transformative impact of this initiative, projecting improvements in both the quality of life and clinical outcomes for individuals with type 1 diabetes across England.

Further, she underscored the importance of recognising symptoms such as increased urination, excessive thirst, fatigue, and unexplained weight loss, urging timely intervention for diagnosis.

Professor Partha Kar, NHS national speciality advisor for diabetes, lauded the Hybrid Closed Loop systems for their ability to enhance medical care and elevate the overall quality of life for recipients.

She said," the device detects your glucose levels, transmits the readings to the delivery system, known as the pump, which then initiates the process of determining the required insulin dosage."

With the endorsement from the National Institute of Health Care and Excellence (NICE), NHS England has laid out a comprehensive 5-year implementation strategy, ensuring equitable access to the Hybrid Closed Loop system.

Moreover, Health Minister Andrew Stephenson hailed the introduction of the technology as a significant step towards simplifying diabetes management and improving outcomes for individuals with type 1 diabetes.

"People living with type 1 diabetes face the constant stress of needing to monitor their blood glucose levels to stay healthy and avoid complications."

"This new technology will ease the burden on patients and allow them to manage their condition more easily, without needing to draw blood or wear a continuous glucose monitor," he added.

The rollout of the artificial pancreas has garnered widespread praise from recipients, with many attesting to its transformative impact on their lives calling it "a game changer" and hassle-free to use.

More For You

Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less